Liquidia Technologies develops and commercializes medicines for rare cardiopulmonary diseases. Its products and services include inhaled therapies, drug development, and manufacturing support for patients, healthcare providers, and pharmaceutical partners.
Liquidia Technologies products and services overview:
Revenue: ~$14 million
Employees: 120
Headquarters: Morrisville, United States (USA)
Liquidia Technologies is one of the...
Liquidia Technologies is a company listed under the stock ticker LQDA (US).
View the org chart displaying its 36 main executives
Create your alert
to follow the executive moves at Liquidia Technologies.
Liquidia Technologies has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.